verified SJR 0,119 · Q4 • database Scopus / SJR & Web of Science indexed

Spain · Clarivate

workspace_premium Q4 — Pharmacology lock Subscription

Drugs of the Future

Drugs of the Future is an interdisciplinary biomedical research journal that publishes well-documented, peer-reviewed articles on topics emerging from the confluence of scientific fields including chemistry, biology, pharmacology, genomics and medicine. The journal identifies and...

ISSN: 0377-8282

Publisher: Clarivate

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,119 Q4

H-index 47

Acceptance rate pie_chart

31%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,119

H-index

Docs (year)

Docs 3y

194

Total refs

Cites 3y

Citable 3y

193

Cites/Doc 2y

0.14

Ref/Doc

0.0

Immediate OA

- €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bitolterol

Y 8004

D-32

Cloprednol

Clazolimine

Cartazolate

Carprofen

Carcainium chloride

Carbuterol

Camazepam

Butibufen

Buspirone

SHOW MORE ARTICLES

Bunolol

15-Methyl prostaglandin F 2 alpha

Benzidol

BDH-7538

Auranofin

Amoxapine

Alprazolam

Alletorphine

Aliflurane

Albendazole

AL-1965

Acrivastine

FAQs

Drugs of the Future has an SJR of 0,119 (best quartile Q4) in the CountryOfPapers database.

Immediate OA APC is not available (NPD). Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Drugs of the Future is 31%.

Drugs of the Future

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Drugs of the Future?

What is the APC / publication cost?

What is the acceptance rate?